Union Bancaire Privee’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.1K Hold
1,910
﹤0.01% 420
2026
Q1
$47.4K Hold
1,910
﹤0.01% 447
2025
Q4
$55.5K Hold
1,910
﹤0.01% 434
2025
Q3
$51.5K Hold
1,910
﹤0.01% 421
2025
Q2
$46.4K Hold
1,910
﹤0.01% 423
2025
Q1
$41.2K Hold
1,910
﹤0.01% 442
2024
Q4
$45.3K Buy
+1,910
New +$47K ﹤0.01% 495

Other funds holding ARKG

Union Bancaire Privee's ARKG Position: Q2 2026 in Review

Union Bancaire Privee held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 1,910 shares worth $81.1K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Union Bancaire Privee first reported a position in ARKG in Q4 2024 and has held it in 7 quarters since. 104 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Union Bancaire Privee held 1,910 shares of ARK Genomic Revolution ETF worth $81.1K as of Q2 2026.
  • Union Bancaire Privee left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #420 holding.
  • Union Bancaire Privee first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 7 quarters since.
  • 104 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.